Metabolic syndrome as a predictor of stroke in patients having achieved complete coronary revascularisation
Document Actions
The study aimed to investigate the relationship between metabolic syndrome and stroke in 1836 consecutive patients having achieved complete coronary revascularisation, metabolic syndrome being defined by the modified AHA/NHLBI criteria. Among the study population, there were 826 patients with metabolic syndrome and 1010 patients without metabolic syndrome. The mean duration of follow-up was 11.4 years. Cox proportional hazards regression analyses revealed that risk of stroke was significantly higher among patients with metabolic syndrome than among those without metabolic syndrome (HR 1.3; 95% CI 1.0-2.1; P=0.045). Thus, metabolic syndrome appears to be a significant predictor of stroke, as well as of all-cause mortality and cardiac mortality, among patients having achieved complete coronary revascularisation.
Abstract
